Literature DB >> 16040875

Does carbon dioxide retention during exercise predict a more rapid decline in FEV1 in cystic fibrosis?

S M Javadpour1, H Selvadurai, D L Wilkes, J Schneiderman-Walker, A L Coates.   

Abstract

BACKGROUND: Carbon dioxide (CO2) retention during exercise is uncommon in mild to moderate lung disease in cystic fibrosis (CF). The ability to deal with increased CO2 is dependent on the degree of airflow limitation and inherent CO2 sensitivity. CO2 retention (CO2R) can be defined as a rise in P(ET)CO2 tension of > or =5 mm Hg with exercise together with a failure to reduce P(ET)CO2 tension after peak work by at least 3 mm Hg by the termination of exercise. AIM: To ascertain if carbon dioxide retention during exercise is associated with more rapid decline in lung function.
METHODS: Annual spirometric and exercise data from 58 children aged 11-15 years, with moderate CF lung disease between 1996 and 2002 were analysed.
RESULTS: The mean FEV1 at baseline for the two groups was similar; the CO2R group (n = 15) was 62% and the non-CO2 retention group (CO2NR) was 64% (n = 43). The decline in FEV1 after 12 months was -3.2% (SD 1.1) in the CO2R group and -2.3% (SD 0.9) in the CO2NR group. The decline after 24 months was -6.3% (SD 1.3) and -1.8% (SD 1.1) respectively. After 36 months, the decline in FEV1 was -5.3% (SD 1.2) and -2.6% (SD 1.1) respectively. The overall decline in lung function was 14.8% (SD 2.1) in the CO2R group and 6.7% (SD 1.8) in the CO2NR group. Using the primary outcome measure as a decline in FEV(1) of >9%, final multivariate analysis showed that the relative risks for this model were (95% CIs in parentheses): DeltaP(ET)CO2 11.61 (3.41 to 24.12), peak VO2 1.23 (1.10 to 1.43), and initial FEV(1) 1.14 (1.02 to 1.28).
CONCLUSION: Results show that the inability to defend carbon dioxide during exercise is associated with a more rapid decline in lung function.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16040875      PMCID: PMC1720533          DOI: 10.1136/adc.2004.070110

Source DB:  PubMed          Journal:  Arch Dis Child        ISSN: 0003-9888            Impact factor:   3.791


  17 in total

1.  Five- to seven-year course of pulmonary function in cystic fibrosis.

Authors:  M Corey; H Levison; D Crozier
Journal:  Am Rev Respir Dis       Date:  1976-12

2.  The "worth" of routine spirometry in a cystic fibrosis clinic.

Authors:  M A Wall; P C LaGesse; J A Istvan
Journal:  Pediatr Pulmonol       Date:  1998-04

3.  Cardiac output and arterial blood gases during exercise in pubertal boys.

Authors:  B O Eriksson; G Grimby; B Saltin
Journal:  J Appl Physiol       Date:  1971-09       Impact factor: 3.531

4.  A new prognostic score and clinical evaluation system for cystic fibrosis.

Authors:  L M Taussig; J Kattwinkel; W T Friedewald; P A Di Sant'Agnese
Journal:  J Pediatr       Date:  1973-03       Impact factor: 4.406

5.  Cardio-respiratory response to exercise in normal children.

Authors:  S Godfrey; C T Davies; E Wozniak; C A Barnes
Journal:  Clin Sci       Date:  1971-05       Impact factor: 6.124

6.  Pulmonary function and response to exercise in cystic fibrosis.

Authors:  S Godfrey; M Mearns
Journal:  Arch Dis Child       Date:  1971-04       Impact factor: 3.791

7.  Longitudinal analysis of pulmonary function decline in patients with cystic fibrosis.

Authors:  M Corey; L Edwards; H Levison; M Knowles
Journal:  J Pediatr       Date:  1997-12       Impact factor: 4.406

8.  Prediction of mortality in patients with cystic fibrosis.

Authors:  E Kerem; J Reisman; M Corey; G J Canny; H Levison
Journal:  N Engl J Med       Date:  1992-04-30       Impact factor: 91.245

9.  Ventilation, respiratory center output, and contribution of the rib cage and abdominal components to ventilation during CO2 rebreathing in children with cystic fibrosis.

Authors:  A L Coates; K J Desmond; J Milic-Emili; P H Beaudry
Journal:  Am Rev Respir Dis       Date:  1981-11

10.  The prognostic value of exercise testing in patients with cystic fibrosis.

Authors:  P A Nixon; D M Orenstein; S F Kelsey; C F Doershuk
Journal:  N Engl J Med       Date:  1992-12-17       Impact factor: 91.245

View more
  4 in total

1.  The Coping with Asthma Study: a randomised controlled trial of a home based, nurse led psychoeducational intervention for adults at risk of adverse asthma outcomes.

Authors:  J R Smith; S Mildenhall; M J Noble; L Shepstone; M Koutantji; M Mugford; B D W Harrison
Journal:  Thorax       Date:  2005-07-29       Impact factor: 9.139

2.  Overall and differentiated sensory responses to cardiopulmonary exercise test in patients with cystic fibrosis: kinetics and ability to predict peak oxygen uptake.

Authors:  Mathieu Gruet; Laurent Mely; Jean-Marc Vallier
Journal:  Eur J Appl Physiol       Date:  2018-07-09       Impact factor: 3.078

Review 3.  Exercise testing and training with the young cystic fibrosis patient.

Authors:  Daniel Stevens; Craig A Williams
Journal:  J Sports Sci Med       Date:  2007-09-01       Impact factor: 2.988

4.  Ventilatory abnormalities in patients with cystic fibrosis undergoing the submaximal treadmill exercise test.

Authors:  Paloma Lopes Francisco Parazzi; Fernando Augusto de Lima Marson; Maria Angela Gonçalves de Oliveira Ribeiro; Celize Cruz Bresciani de Almeida; Luiz Cláudio Martins; Ilma Aparecida Paschoal; Adyleia Aparecida Dalbo Contrera Toro; Camila Isabel Santos Schivinski; Jose Dirceu Ribeiro
Journal:  BMC Pulm Med       Date:  2015-05-19       Impact factor: 3.317

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.